CJC-1295 (No DAC) + Ipamorelin Product Specifications
Product Identification
Product Name: CJC-1295 (No DAC) + Ipamorelin
Full Name: Modified GRF (1-29) + Ipamorelin
Compound Type: Synthetic peptide blend
Research Category: Growth hormone signaling / GHRH and GHSR research
Blend Composition: CJC-1295 (No DAC) + Ipamorelin
Total Peptide Content: 10 mg
Composition: 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin
Presentation: Single research vial
Physical Form: Lyophilized powder
Batch: CP102605A
Molecular Structure and Composition
CJC-1295 (No DAC)
Alternative Name: Modified GRF (1-29), Mod GRF (1-29)
Compound Classification: GHRH analogue
Peptide Length: 29 amino acids
Molecular Formula: C152H252N44O42
Molecular Weight: Approximately 3367.9 g/mol
CAS Number: 863288-34-0
Structural Characteristic: Modified GRF (1-29) analogue without Drug Affinity Complex
Primary Research Target: Growth hormone-releasing hormone receptor
The No-DAC form is chemically distinct from CJC-1295 with DAC and should not be identified using the molecular specifications of the DAC-containing compound.
Ipamorelin
Compound Classification: Growth hormone secretagogue / ghrelin mimetic
Peptide Length: 5 amino-acid residues
Molecular Formula: C38H49N9O5
Molecular Weight: 711.9 g/mol
CAS Number: 170851-70-4
PubChem CID: 9831659
Peptide Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Primary Research Target: Growth hormone secretagogue receptor (GHSR / ghrelin receptor)
Physical Characteristics
Appearance: White to off-white lyophilized powder
Physical State: Lyophilized peptide material
Container: Sealed research vial
Nominal Content: 10 mg total peptide blend
Composition Ratio: 1:1 CJC-1295 (No DAC) to Ipamorelin
The appearance of lyophilized research material may vary slightly according to manufacturing, lyophilization and formulation conditions without necessarily indicating a difference in peptide identity.
Analytical Characterization
Primary Purity Method: High-Performance Liquid Chromatography (HPLC)
Identity Testing: Mass-based analytical confirmation where specified on the corresponding Certificate of Analysis
Purity Standard: Target ≥99% peptide purity
Quantitative Content: Batch-specific where independently tested
Because the product contains two separate peptide compounds, analytical interpretation should account for the identity and chromatographic behavior of each component rather than treating the blend as a single molecular entity.
Batch-Testing Information
Batch: CP102605A
Batch-specific analytical documentation should be used to confirm the purity, identity and quantitative characteristics of the material supplied.
Analytical results apply only to the specific batch tested and should not automatically be applied to separate manufacturing lots.
Where available, the corresponding Certificate of Analysis should be reviewed for the actual analytical results associated with this batch.
Storage and Stability
Recommended Storage: 2–8°C
Storage Condition: Refrigerated
Light Exposure: Protect from direct light
Moisture Exposure: Protect from excessive moisture and humidity
Form: Store in lyophilized form under appropriate controlled conditions until required for laboratory analysis.
Peptide stability can be affected by temperature, moisture, light exposure and repeated environmental changes. Long-term stability should be determined according to validated laboratory procedures and batch-specific analytical data.
Analytical Limitations
HPLC purity represents the relative chromatographic purity of detectable components under the analytical conditions used and should not independently be interpreted as confirmation of peptide identity, absolute peptide quantity, sterility or biological activity.
Identity testing and quantitative content determination require appropriate analytical methods and reference standards.
Results from one production batch should not automatically be extrapolated to another batch.
Intended-Use Restrictions
CJC-1295 (No DAC) + Ipamorelin is supplied exclusively as a laboratory research material.
The product is intended for analytical, biochemical and experimental research conducted by appropriately qualified individuals in controlled laboratory environments.
Not for human consumption.
Not for veterinary use.
Not for diagnostic or therapeutic use.
Not intended to diagnose, treat, cure or prevent any disease or medical condition.
Documentation Notice
Product specifications describe the chemical, physical and analytical characteristics of the research material and are provided for laboratory identification and documentation purposes.
Scientific information describing biological pathways or published experimental findings is provided for research context only and should not be interpreted as medical advice, therapeutic guidance or evidence of an approved clinical application.
For batch-specific information, researchers should refer to the corresponding Certificate of Analysis and analytical documentation supplied for Batch CP102605A